Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 3rd Quarter

16 Sep 2021 07:00

RNS Number : 9195L
Income & Growth VCT (The) PLC
16 September 2021
 

 

The Income & Growth VCT plc

("the Company")

LEI: 213800FPC15FNM74YD92

 

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2021

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2021. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 June 2021

(unaudited)

At 31 March 2021

(unaudited)

Net assets attributable toshareholders

£120.31 million

£111.95 million

Shares in issue

117,734,097

118,200,511

Net asset value (NAV) per share

102.19 pence

94.71 pence

Cumulative dividends paid

131.50 pence

131.50 pence

Cumulative Total return (net asset value basis) per share since inception

233.69 pence

226.21 pence

The NAV per share has increased by 7.48 pence in the quarter (an increase of 7.9% upon the opening NAV per share). This positive performance is principally due to a continued rise in unrealised portfolio valuations.

 

 

Proposed change in management arrangements

As announced by the Company via RNS on 10 September 2021, Mobeus Equity Partners LLP (Mobeus), the investment adviser to the Company has announced the sale of its VCT fund and investment management business to a subsidiary of Gresham House plc (Gresham House). As part of the sale, the Board has agreed to the novation of the investment advisory arrangements from Mobeus to Gresham House subject to completion of the sale. Gresham House is a fast growing, specialist fund group, with a long-term commitment to the VCT industry and is the existing investment manager of the Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc (the Baronsmead VCTs). The entire core management, investment and operational teams involved with the Mobeus VCTs will all transfer to Gresham House in connection with this transaction to form a significantly enlarged team that will manage both the Mobeus VCTs and the Baronsmead VCTs. The Board can confirm that no material changes are being made to the terms of the investment advisory arrangements. Shareholders can also be assured that the Board's track record of governance and independence will be maintained.

 

 

INTERIM DIVIDEND

The Board declared an interim dividend of 5.00 pence per share for the year ending 30 September 2021. This dividend was paid to Shareholders on 23 July 2021 who were on the Register on 25 June 2021 and brings cumulative dividends paid per share to 136.50 pence per share, and also reduces the Company's Net Asset Value by a corresponding amount.

 

 

SHARE BUY-BACKS

 

On 25 June 2021, the Company purchased 466,414 of its own ordinary shares at a price of 85.22 pence per share for cancellation.

 

 

DIVIDEND INVESTMENT SCHEME

 

After the period end, on 23 July 2021, the Company allotted 1,178,669 shares to participants of the Dividend Investment Scheme at a price of 89.71 pence per share, being the latest published NAV at 31 March 2021 of 94.71 pence per share adjusted for the 5.00 pence per share interim dividend. Following this allotment, the Company has 118,912,766 ordinary shares of 1 penny each in issue.

 

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New investments during the period

On 22 June 2021, a new investment of £0.91 million was made into Legatics, a SaaS LegalTech software business.

 

On 25 June 2021, a new investment of £0.84 million was made into Pets' Kitchen (trading as Vet's Klinic), a veterinary clinics business and pet food provider.

 

Follow-on investments during the period

On 16 April 2021 and 18 May 2021, follow-on investments totalling £0.25 million were made into Caledonian Leisure, a provider of UK leisure and experience breaks.

 

On 26 May 2021, a follow-on investment of £0.39 million was made into Bella & Duke, a premium frozen raw dog food provider.

 

On 27 June 2021, a follow-on investment of £0.08 million was made into Spanish Restaurant Group Limited (trading as Tapas Revolution), a Spanish restaurant chain.

Loan repayments during the period

On 1 April 2021, a loan repayment of £0.32 million was received by the Company from Vian Marketing Limited (trading as Red Paddle).

 

On 28 May 2021, a loan repayment of £0.46 million was received by the Company from MPB Group Limited.

 

 

Other proceeds received during the period.

 

On 12 April 2021, the Company received further proceeds of £0.04 million in respect of Vectair Holdings Limited, an investment realised in a previous year.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

Follow-on investments after the period end

On 5 August 2021, a follow-on investment of £0.95 million was made into MyTutor, a digital tutoring marketplace.

 

Partial realisation after the period end

On 6 August 2021, the Company sold part of its original equity holding in MyTutor to a large strategic investor generating proceeds of £0.95 million and a £0.70 million realised gain for the Company over the original cost of the equity shares sold. In isolation, the impact of this partial sale is a 0.10 pence uplift in NAV per share compared to the 30 June 2021 NAV per share of 102.19 pence, referred to above.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

 

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVUNRAWUKAAR
Date   Source Headline
20th Dec 20194:00 pmRNSFundraising Update
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
16th Dec 20199:45 amRNSTransaction in Own Shares
13th Dec 20194:30 pmRNSAnnual Financial Report
6th Dec 20194:45 pmRNSDividend Investment Scheme - Recommencement
6th Dec 20194:45 pmRNSAnnual Results for the year ended 30 Sep 2019
26th Nov 20194:09 pmRNSDirector Declaration
14th Nov 201912:00 pmRNSFundraising Update
12th Nov 20192:30 pmRNSDirectorate Change
25th Oct 20194:00 pmRNSPublication of a Prospectus
18th Oct 20195:20 pmRNSDirectorate Change
3rd Oct 20199:52 amRNSDirector Declaration
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
18th Sep 20194:01 pmRNSDividend Declaration
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
13th Aug 20193:19 pmRNSInterim Management Statement - 3rd Quarter
31st Jul 20197:00 amRNSReduction of Capital
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
2nd Jul 20199:11 amRNSRealisation of investment
7th Jun 20195:35 pmRNSTransaction in Own Shares
5th Jun 20194:44 pmRNSTransaction in Own Shares
4th Jun 201911:05 amRNSHalf-year Report
30th May 20193:38 pmRNSHalf-year Report
26th Mar 20195:25 pmRNSTransaction in Own Shares
15th Feb 20194:30 pmRNSTransaction in Own Shares
6th Feb 20191:54 pmRNSInterim Management Statement - 1st Quarter
6th Feb 20191:42 pmRNSResult of AGM
19th Dec 20184:32 pmRNSTransaction in Own Shares
19th Dec 20183:50 pmRNSAnnual Financial Report
17th Dec 20189:25 amRNSTransaction in Own Shares
12th Dec 20182:25 pmRNSDividend Investment Scheme - Suspension
12th Dec 20182:24 pmRNSFinal Results for year ended 30 September 2018
26th Sep 20184:54 pmRNSTransaction in Own Shares
13th Sep 201811:59 amRNSInterim Management Statement to 30 June 2018
14th Aug 20189:42 amRNSNet Asset Value(s)
20th Jul 20185:41 pmRNSTransaction in Own Shares
2nd Jul 20184:18 pmRNSTotal Voting Rights
21st Jun 20184:24 pmRNSDirector/PDMR Shareholding
21st Jun 20184:20 pmRNSDirector/PDMR Shareholding
21st Jun 20184:19 pmRNSIssue of Equity
11th Jun 201811:13 amRNSTransaction in Own Shares
15th May 201812:59 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.